Medications such as semaglutide (Wegovy) and liraglutide (Saxenda) are licensed for weight management, while other GLP-1 receptor agonists like dulaglutide (Trulicity) are licensed only for type 2 diabetes in the UK
Tirzepatide built on it by adding GIP receptor activity, producing the dual-agonist class
Regular monitoring allows her to assess progress, treatment tolerance, eating patterns, and overall health while making appropriate adjustments designed to support safe and sustainable weight management
Multi-system Healing Support: Beyond musculoskeletal benefits, it supports multiple bodily systems, including gastrointestinal, neurological, and cardiovascular, offering a holistic approach to health
These drugs belong to a class called GLP-1 receptor agonists (GLP-1 RAs), or in the case of tirzepatide (Mounjaro, Zepbound), dual GLP-1/GIP RAs
Raising serum glutathione is the ultimate measure of a glutathione supplement's efficacy because it represents system-wide glutathione levels